4//SEC Filing
Febbo Phillip G. 4
Accession 0001384101-24-000186
CIK 0001384101other
Filed
Dec 5, 7:00 PM ET
Accepted
Dec 6, 4:34 PM ET
Size
5.2 KB
Accession
0001384101-24-000186
Insider Transaction Report
Form 4
VERACYTE, INC.VCYT
Febbo Phillip G.
Chief Scientific & Med Officer
Transactions
- Sale
Common Stock
2024-12-04$44.09/sh−3,934$173,447→ 82,414 total
Footnotes (2)
- [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 4, 2024.
- [F2]Represents weighted average sales price. Sale prices for the transactions range from $43.60 to $44.46. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
Documents
Issuer
VERACYTE, INC.
CIK 0001384101
Entity typeother
Related Parties
1- filerCIK 0001649245
Filing Metadata
- Form type
- 4
- Filed
- Dec 5, 7:00 PM ET
- Accepted
- Dec 6, 4:34 PM ET
- Size
- 5.2 KB